Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
0.58%0.66%17.64x1.99x3.78x9.76x11.31x 67.88B
0.6%0.61%26.33x3.98x5.45x16.01x19.85x 53.23B
-.--%-.--%37.7x7.74x12.83x24.43x28.6x 48.71B
3.5%3.59%-43.2x2.42x3.1x9.18x10.71x 38.98B
-.--%-.--%24.81x1.59x3.46x11.92x13.71x 29.55B
-.--%-.--%67.61x4.26x3.45x25.63x27.71x 23.75B
-.--%-.--%-6.42x3.89x8.92x-5.49x-5.13x 22.07B
-.--%0.05%64.54x5.8x6.33x43.58x49.16x 19.84B
-.--%-.--%24.4x3.58x5.22x13.67x18.89x 16.57B
-.--%-.--%-37.81x-6.71x18.02x-49.34x-57.03x 16.49B
-.--%-.--%-115.63x12625.53x12.42x-88.9x-123.91x 12.27B
-.--%-.--%17.84x - 3.66x14.14x16.51x 11.65B
0.16%0.17%57.08x23.28x34.59x48.92x50.45x 11.38B
-.--%-.--%47.11x - - - - 10.37B
2.64%3.01%13.06x1.17x1.86x7.5x10.13x 6.74B
0.37%0.43%27.84x - 7.47x19.81x23.66x 5.69B
1.62%1.75%14.09x1.25x2.4x6.33x7.57x 5.44B
-.--%-.--%-110.75x - - - - 5.44B
Average 0.53% 0.57% 7.01x 905.70x 8.31x 6.70x 6.39x 22.56B
Weighted average by Cap. 0.59% 0.62% 13.93x 419.07x 7.28x 10.27x 11.34x
Biopharmaceuticals